These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9566383)
1. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Mackenzie IR; Munoz DG Neurology; 1998 Apr; 50(4):986-90. PubMed ID: 9566383 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Halliday G; Robinson SR; Shepherd C; Kril J Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory drugs and Alzheimer-type pathology in aging. Mackenzie IR Neurology; 2000 Feb; 54(3):732-4. PubMed ID: 10680812 [TBL] [Abstract][Full Text] [Related]
4. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
6. Role of microglia in senile plaque formation. Mackenzie IR; Hao C; Munoz DG Neurobiol Aging; 1995; 16(5):797-804. PubMed ID: 8532113 [TBL] [Abstract][Full Text] [Related]
7. Microglia as a potential bridge between the amyloid beta-peptide and tau. Kitazawa M; Yamasaki TR; LaFerla FM Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802 [TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. Wang D; Munoz DG J Neuropathol Exp Neurol; 1995 Jul; 54(4):548-56. PubMed ID: 7602328 [TBL] [Abstract][Full Text] [Related]
10. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives]. Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410 [TBL] [Abstract][Full Text] [Related]
11. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Sheng JG; Mrak RE; Griffin WS Acta Neuropathol; 1998 Mar; 95(3):229-34. PubMed ID: 9542587 [TBL] [Abstract][Full Text] [Related]
12. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology. van Groen T; Miettinen P; Kadish I J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852 [TBL] [Abstract][Full Text] [Related]
13. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis. Lee M; McGeer E; McGeer PL Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677 [TBL] [Abstract][Full Text] [Related]
14. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
15. Indomethacin reverses the microglial response to amyloid beta-protein. Netland EE; Newton JL; Majocha RE; Tate BA Neurobiol Aging; 1998; 19(3):201-4. PubMed ID: 9661994 [TBL] [Abstract][Full Text] [Related]
16. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology. Martin E; Boucher C; Fontaine B; Delarasse C Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233 [TBL] [Abstract][Full Text] [Related]
17. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Vehmas AK; Kawas CH; Stewart WF; Troncoso JC Neurobiol Aging; 2003; 24(2):321-31. PubMed ID: 12498966 [TBL] [Abstract][Full Text] [Related]
18. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Arvanitakis Z; Grodstein F; Bienias JL; Schneider JA; Wilson RS; Kelly JF; Evans DA; Bennett DA Neurology; 2008 Jun; 70(23):2219-25. PubMed ID: 18519870 [TBL] [Abstract][Full Text] [Related]